ANTONIO GREGORIAN: Open Payments
NPI 1487740080 · CLIFTON PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,097 in 148 payments from 20 companies in 2025. Trend: 2023 $1,509 · 2024 $2,320 · 2025 $3,097
Food & beverage: $3,097
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $668 |
| ABBVIE INC. | 29 | $519 |
| Novo Nordisk Inc | 14 | $371 |
| GlaxoSmithKline, LLC. | 8 | $211 |
| PFIZER INC. | 24 | $185 |
| Amgen Inc. | 12 | $163 |
| Otsuka America Pharmaceutical, Inc. | 5 | $126 |
| Phathom Pharmaceuticals, Inc. | 8 | $117 |
| Lilly USA, LLC | 6 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $107 |
Products named: AIRSUPRA, UBRELVY, FARXIGA, VRAYLAR, Ozempic, NURTEC ODT, SHINGRIX, Wegovy.
Industry payments across NY — which companies pay providers there.
